ENVERIC BIOSCIENCES INC (ENVB) Stock News

USA - NASDAQ:ENVB - US29405E4061 - Common Stock

0.6881 USD

-0.01 (-1.18%)

Last: 10/8/2025, 12:44:53 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ENVB Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill - Mentions: PLUG XELB ASNS RCAT ...

News Image

These stocks are gapping in today's session

5 days ago - By: Chartmill - Mentions: PC XELB ASNS SPRB ...

News Image

These stocks that are showing activity before the opening bell on Friday.

6 days ago - By: Enveric Biosciences

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

8 days ago - By: Chartmill - Mentions: NBY WOLF RVSN CANF ...

News Image

Stay updated with the stocks that are on the move in today's pre-market session.

9 days ago - By: Benzinga - Mentions: NBY NEOG PMI APDN ...

12 Health Care Stocks Moving In Monday's After-Market Session

9 days ago - By: Chartmill - Mentions: NBY WOLF UUUU FGL ...

News Image

Stay updated with the stocks that are on the move in today's after-hours session.

20 days ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

21 days ago - By: Benzinga - Mentions: USBC CURX CODX SPRC ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

21 days ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

21 days ago - By: Enveric Biosciences

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

22 days ago - By: Enveric Biosciences

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

a month ago - By: Enveric Biosciences

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

a month ago - By: Enveric Biosciences

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

a month ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

2 months ago - By: Enveric Biosciences

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

3 months ago - By: Enveric Biosciences

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

3 months ago - By: Enveric Biosciences

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

4 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

4 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Participation in 2025 BIO International Convention

4 months ago - By: Enveric Biosciences

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

4 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

4 months ago - By: Enveric Biosciences

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

5 months ago - By: Enveric Biosciences

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

5 months ago - By: Enveric Biosciences

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

6 months ago - By: Enveric Biosciences

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

7 months ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Participating in BIO-Europe Spring®

7 months ago - By: Enveric Biosciences

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

7 months ago - By: Enveric Biosciences

Enveric Biosciences CEO Issues Letter to Shareholders